Compare STXS & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | AXR |
|---|---|---|
| Founded | 1990 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 132.0M |
| IPO Year | 2004 | 2010 |
| Metric | STXS | AXR |
|---|---|---|
| Price | $1.36 | $22.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 590.0K | 9.7K |
| Earning Date | 05-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | ★ $29,346,617.00 | $12,831,000.00 |
| Revenue This Year | $28.22 | $10.12 |
| Revenue Next Year | $30.47 | N/A |
| P/E Ratio | ★ N/A | $11.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.24 | $17.61 |
| 52 Week High | $3.59 | $29.01 |
| Indicator | STXS | AXR |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 42.90 |
| Support Level | $1.30 | $21.68 |
| Resistance Level | $1.96 | $23.52 |
| Average True Range (ATR) | 0.06 | 0.51 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 40.05 | 60.57 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.